Advertisement

Transfusion Support

  • Esteban Gomez
  • Anurag K. AgrawalEmail author
  • Caroline A. Hastings
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

The utilization of appropriate transfusion therapy is a vital aspect in the prevention of morbidity in pediatric oncology patients. Practitioners must be cognizant of the risks and benefits of transfusion as well as the appropriate transfusion practices in immunocompromised patients. Here we review the evidence regarding transfusion management practices in pediatric cancer patients with anemia, thrombocytopenia and neutropenia as well as practice in managing potential transfusion reactions. Where an evidence basis is lacking, we review consensus guidelines in both the pediatric and adult cohorts.

Keywords

Hematopoietic Stem Cell Transplantation Iron Overload Disseminate Intravascular Coagulation Transfusion Reaction Pediatric Oncology Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Agrawal AK, Hastings CH, Feusner J (2011) Hematologic supportive care in children with cancer. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 6th edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  2. Agrawal AK, Hsu E, Quirolo K et al (2012) Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary. Pediatr Blood Cancer 58:466–468PubMedGoogle Scholar
  3. Alessandrino EP, Della Porta MG, Bacigalupo A et al (2010) Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95:476–484PubMedCentralPubMedGoogle Scholar
  4. Almeida-Porada GD, Ascensao JL (1996) Cytomegalovirus as a cause of pancytopenia. Leuk Lymphoma 21:217–223PubMedGoogle Scholar
  5. Alpert G, Fleisher GR (1984) Complications of infection with Epstein-Barr virus during childhood: a study of children admitted to the hospital. Pediatr Infect Dis 3:304–307PubMedGoogle Scholar
  6. Anderson KC, Goodnough LT, Sayers M et al (1991) Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 77:2096–2102PubMedGoogle Scholar
  7. Andreu G (2009) Transfusion-associated circulatory overload and transfusion-related acute lung injury: diagnosis, pathophysiology, management and prevention. ISBT Sci Ser 4:63–71Google Scholar
  8. Angelucci E, Brittenham GM, McLaren CE et al (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343:327–331PubMedGoogle Scholar
  9. Arduino MJ, Bland LA, Tipple MA et al (1989) Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 27:1483–1485PubMedCentralPubMedGoogle Scholar
  10. Armand P, Kim HT, Cutler CS et al (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586–4588PubMedCentralPubMedGoogle Scholar
  11. Athale UH, Chan AK (2007) Hemorrhagic complications in pediatric hematologic malignancies. Semin Thromb Hemost 33:408–415PubMedGoogle Scholar
  12. Ballas SK (2001) Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 38:30–36PubMedGoogle Scholar
  13. Barrera R, Mina B, Huang Y et al (1996) Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 78:2025–2030PubMedGoogle Scholar
  14. Barrett NA, Kam PC (2006) Transfusion-related acute lung injury: a literature review. Anesthesia 61:777–785Google Scholar
  15. Belt RJ, Leite C, Haas CD, Stephens RL (1978) Incidence of hemorrhagic complications in patients with cancer. JAMA 239:2571–2574PubMedGoogle Scholar
  16. Benjamin RJ, Anderson KS (2002) What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol 42:163–171PubMedGoogle Scholar
  17. Bishton M, Chopra R (2004) The role of granulocyte transfusions in neutropenic patients. Br J Haematol 127:501–508PubMedGoogle Scholar
  18. Blajchman MA, Goldman M, Freedman JJ, Sher GD (2001) Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev 15:1–20PubMedGoogle Scholar
  19. Blumberg N, Fine L, Gettings KF, Heal JM (2005) Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions. Transfusion 45:1632–1639PubMedGoogle Scholar
  20. Bolton-Maggs PH, Murphy MF (2004) Blood transfusion. Arch Dis Child 89:4–7PubMedCentralPubMedGoogle Scholar
  21. Bowden RA, Slichter SJ, Sayers M et al (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86:3598–3603PubMedGoogle Scholar
  22. British Committee for Standards in Hematology (BCSH) (2003) Guidelines on the use of platelet transfusions. Br J Haematol 122:10–23Google Scholar
  23. Brittenham GM, Sheth S, Allen CJ et al (2001) Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 38:37–56PubMedGoogle Scholar
  24. Buchanan GR (2005) Blood transfusions in children with cancer and hematologic disorders: why, when, and how? Pediatr Blood Cancer 44:114–116PubMedGoogle Scholar
  25. Bürger B, Zimmermann M, Mann G et al (2003) Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21:184–188PubMedGoogle Scholar
  26. Busch MP, Glynn SA, Stramer SL (2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45:254–264PubMedGoogle Scholar
  27. Carr R, Hutton JL, Jenkins JA et al (1990) Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 75:408–413PubMedGoogle Scholar
  28. Cazzola M (2000) Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin. Med Oncol 17:S11–S16PubMedGoogle Scholar
  29. Cazzola M, Malcovati L (2005) Myelodysplastic syndromes—coping with ineffective hematopoiesis. N Engl J Med 352:536–538PubMedGoogle Scholar
  30. Chanock SJ, Gorlin JB (1996) Granulocyte transfusions. Time for a second look. Infect Dis Clin North Am 10:327–343PubMedGoogle Scholar
  31. Chu RW (1999) Leukocytes in blood transfusion: adverse effects and their prevention. Hong Kong Med J 5:280–284PubMedGoogle Scholar
  32. Church GD, Price C, Sanchez R (2006) Transfusion-related acute lung injury in the paediatric patient: two case reports and a review of the literature. Transfus Med 16:343–348PubMedGoogle Scholar
  33. Coit DB, Turnbull AD (1988) A safe technique for the placement of implantable vascular access devices in patients with thrombocytopenia. Surg Gynecol Obstet 167:429–431PubMedGoogle Scholar
  34. Consensus Conference (1987) Platelet transfusion therapy. JAMA 257:1777–1780Google Scholar
  35. Contreras M (1998) The appropriate use of platelets: an update from the Edinburgh Consensus Conference. Br J Haematol 101:10–12PubMedGoogle Scholar
  36. Couban S, Carruthers J, Andreou P et al (2002) Platelet transfusion in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 42:753–758PubMedGoogle Scholar
  37. Cunningham RS (2003) Anemia in the oncology patient: cognitive function and cancer. Cancer Nurs 26:38S–42SPubMedGoogle Scholar
  38. Darbari DS, Kple-Faget P, Kwagyan J et al (2006) Circumstances of death in adult sickle cell disease patients. Am J Hematol 81:858–863PubMedGoogle Scholar
  39. Davies SC, Kinsey SE (1994) Clinical aspects of paediatric blood transfusion: cellular components. Vox Sang 67:50–53PubMedGoogle Scholar
  40. Davies P, Robertson S, Hedge S et al (2007) Calculating the required transfusion volume in children. Transfusion 47:212–216PubMedGoogle Scholar
  41. De Ville de Goyet M, Moniotte S, Robert A et al (2013) Iron overload in children undergoing cancer treatments. Pediatr Blood Cancer 60:1982–1987PubMedGoogle Scholar
  42. Dodd RY (2007) Current risk for transfusion transmitted infections. Curr Opin Hematol 14:671–676PubMedGoogle Scholar
  43. Doerfler ME, Kaufman B, Goldenberg AS (1996) Central venous catheter placement in patients with disorders of hemostasis. Chest 110:185–188PubMedGoogle Scholar
  44. Duquesnoy RJ, Filip DJ, Rodey GE et al (1977) Successful transfusion of platelets “mis-matched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 2:219–226PubMedGoogle Scholar
  45. Dutcher JP, Schiffer CA, Aisner J et al (1981) Alloimmunization following platelet transfusion: the absence of a dose–response relationship. Blood 57:395–398PubMedGoogle Scholar
  46. Dwyre DM, Holland PV (2008) Transfusion-associated graft-versus-host disease. Vox Sang 95:85–93PubMedGoogle Scholar
  47. Dwyre DM, Fernando LP, Holland PV (2011) Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 100:92–98PubMedGoogle Scholar
  48. Dzik WH (2002) Leukoreduction of blood components. Curr Opin Hematol 9:521–526PubMedGoogle Scholar
  49. Eder AF, Herron R, Strupp A et al (2007) Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47:599–607PubMedGoogle Scholar
  50. Eid AJ, Brown RA, Patel R, Razonable RR (2006) Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 43:40–48PubMedGoogle Scholar
  51. El-Mahallawy HA, Mansour T, El-Din SE et al (2004) Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol 26:403–406PubMedGoogle Scholar
  52. Emy PY, Levin TL, Sheth SS et al (1997) Iron overload in reticuloendothelial systems of pediatric oncology patients who have undergone transfusions: MR observations. Am J Radiol 168:1011–1015Google Scholar
  53. Eng J, Fish JD (2011) Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 56:368–371PubMedGoogle Scholar
  54. Fasano R, Luban NL (2008) Blood component therapy. Pediatr Clin North Am 55:421–455PubMedGoogle Scholar
  55. Fenaux P, Rose C (2009) Impact of iron overload in myelodysplastic syndromes. Blood Rev 23:S15–S19PubMedGoogle Scholar
  56. Fischer R, Tiemann ED, Engelhardt R et al (1999) Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol 60:289–299PubMedGoogle Scholar
  57. Friedberg RC, Donnelly SF, Boyd JC et al (1993) Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 81:3428–3434PubMedGoogle Scholar
  58. Friedberg RC, Donnelly SF, Mintz PD (1994) Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients. Transfusion 34:215–220PubMedGoogle Scholar
  59. Friedmann AM, Sengul H, Lehmann H et al (2002) Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 16:34–45PubMedGoogle Scholar
  60. Gajjar A, Harrison PL, Sandlund JT et al (2000) Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood 96:3381–3384PubMedGoogle Scholar
  61. Garcia-Manero G, Shan J, Faderl S et al (2008) A prognostic score for patients with low risk myelodysplastic syndrome. Leukemia 22:538–543PubMedGoogle Scholar
  62. Gauvin F, Lacroix J, Robillard P et al (2006) Acute transfusion reactions in the pediatric intensive care unit. Transfusion 46:1899–1908PubMedGoogle Scholar
  63. Geiger TL, Howard SC (2007) Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 21:1–12PubMedCentralPubMedGoogle Scholar
  64. Gelb AB, Leavitt AD (1997) Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 37:624–630PubMedGoogle Scholar
  65. Gibson BE, Todd A, Roberts I et al (2004) Transfusion guidelines for neonates and older children. Br J Haematol 124:433–453PubMedGoogle Scholar
  66. Glatstein M, Oron T, Barak M et al (2005) Posttransfusion equilibration of hematocrit in hemodynamically stable neonates. Pediatr Crit Care Med 6:707–708PubMedGoogle Scholar
  67. Gmür J, Burger J, Schanz U et al (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338:1223–1226PubMedGoogle Scholar
  68. Goldman M, Webert KE, Arnold DM et al (2005) Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 19:2–31PubMedGoogle Scholar
  69. Green DM, Breslow NE, Beckwith JB et al (1998) Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 16:237–245PubMedGoogle Scholar
  70. Grigull L, Pulver N, Goudeva L et al (2006) G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14:910–916PubMedGoogle Scholar
  71. Groopman JE, Itri LM (1999) Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91:1616–1634PubMedGoogle Scholar
  72. Guyatt G, Gutterman D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129:174–181PubMedGoogle Scholar
  73. Halonen P, Mattila J, Suominen P et al (2003) Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics 111:91–96PubMedGoogle Scholar
  74. Heal JM, Blumberg N, Masel D (1987) An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 70:23–30PubMedGoogle Scholar
  75. Heckman KD, Weiner GJ, Davis CS et al (1997) Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 15:1143–1149PubMedGoogle Scholar
  76. Heddle NM (2004) Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion 44:1–4PubMedGoogle Scholar
  77. Heddle NM, Klama LN, Griffith L et al (1993) A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusion. Transfusion 33:794–797PubMedGoogle Scholar
  78. Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM (1994) Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 34:929–934PubMedGoogle Scholar
  79. Hockenberry MJ, Hinds PS, Barrera P et al (2002) Incidence of anemia in children with solid tumors or Hodgkin disease. J Pediatr Hematol Oncol 24:35–37PubMedGoogle Scholar
  80. Hockenberry-Eaton M, Hinds PS (2000) Fatigue in children and adolescents with cancer: evolution of a program of study. Semin Oncol Nurs 16:261–272PubMedGoogle Scholar
  81. Howard JE, Perkins HA (1978) The natural history of alloimmunization to platelets. Transfusion 18:496–503PubMedGoogle Scholar
  82. Howard SC, Gajjar AC, Ribeiro RC et al (2000) Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 284:2222–2224PubMedGoogle Scholar
  83. Howard SC, Gajjar AC, Cheng C et al (2002) Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. JAMA 288:2001–2007PubMedGoogle Scholar
  84. Jayabose S, Tugal O, Ruddy R et al (1993) Transfusion therapy for severe anemia. Am J Pediatr Hematol Oncol 15:324–327PubMedGoogle Scholar
  85. Kaur P, Basu S (2005) Transfusion-transmitted infections: existing and emerging pathogens. J Postgrad Med 51:146–151PubMedGoogle Scholar
  86. Kennedy LD, Case LD, Hurd DD et al (2008) A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion 48:2285–2291PubMedGoogle Scholar
  87. Kickler TS, Ness PM, Baine HG (1988) Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient. Am J Clin Pathol 90:69–72PubMedGoogle Scholar
  88. King KE, Shirey RS, Thoman SK et al (2004) Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 44:25–29PubMedGoogle Scholar
  89. Klein HG, Strauss RG, Schiffer CA (1996) Granulocyte transfusion therapy. Semin Hematol 33:359–368PubMedGoogle Scholar
  90. Klein HG, Dodd RY, Ness PM et al (1997) Current status of microbial contamination of blood components: summary of a conference. Transfusion 37:95–101PubMedGoogle Scholar
  91. Kleinman S, Caulfield T, Chan P et al (2004) Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44:1774–1789PubMedGoogle Scholar
  92. Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116:11S–26SPubMedGoogle Scholar
  93. Kuehnert MJ, Roth VR, Haley NR et al (2001) Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41:1493–1499PubMedGoogle Scholar
  94. Linden JV, Wagner K, Voytovich AE et al (2000) Transfusion errors in New York state: an analysis of 10 years’ experience. Transfusion 40:1207–1213PubMedGoogle Scholar
  95. Ljungman P (2004) Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction. Br J Haematol 125:107–116PubMedGoogle Scholar
  96. Loh AH, Chui CH (2007) Port-A-Cath insertions in acute leukemia: dose thrombocytopenia affect morbidity? J Pediatr Surg 42:1180–1184PubMedGoogle Scholar
  97. Lowell JA, Bothe A Jr (1991) Venous access. Preoperative, operative, and postoperative dilemmas. Surg Clin North Am 71:1231–1246PubMedGoogle Scholar
  98. Luban NL, Drothler D, Moroff G et al (2000) Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 40:348–352PubMedGoogle Scholar
  99. Malcovati L, Della Porta MG, Cazzola M (2006) Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. Haematologica 91:1588–1590PubMedGoogle Scholar
  100. Marec-Berard P, Blay JY, Schell M et al (2003) Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients. J Clin Oncol 21:4235–4238PubMedGoogle Scholar
  101. Massey E, Paulus U, Doree C et al (2009) Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (1):CD005341Google Scholar
  102. Michon J (2002) Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol 39:448–450PubMedGoogle Scholar
  103. Mock V, Olsen M (2003) Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs 19:36–41PubMedGoogle Scholar
  104. Moroff G, Luban NL (1992) Prevention of transfusion-associated graft-versus-host disease. Transfusion 32:102–103PubMedGoogle Scholar
  105. Morrow JF, Braine HG, Kickler TS et al (1991) Septic reactions to platelet transfusions. A persistent problem. JAMA 266:555–558PubMedGoogle Scholar
  106. Myhre BA, McRuer D (2000) Human error—a significant cause of transfusion mortality. Transfusion 40:879–885PubMedGoogle Scholar
  107. Nachman J, Sather HN, Cherlow JM et al (1998) Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children’s Cancer Group. J Clin Oncol 16:920–930PubMedGoogle Scholar
  108. Nash T, Hoffmann S, Butch S et al (2012) Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients. Transfusion 52:2270–2272PubMedGoogle Scholar
  109. Nichols WG, Price TH, Gooley T et al (2003) Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 101:4195–4200PubMedGoogle Scholar
  110. Norfolk DR, Ancliffe PJ, Contreras M et al (1998) Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27–28 November 1997. Synopsis of background papers. Br J Haematol 101:609–617PubMedGoogle Scholar
  111. Norville R, Hinds P, Wilimas J et al (1997) The effects of infusion rate on platelet outcomes and patient responses in children with cancer: an in vitro and in vivo study. Oncol Nurs Forum 24:1789–1793PubMedGoogle Scholar
  112. O’Connell BA, Lee EJ, Rothko K et al (1992) Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 79:527–531PubMedGoogle Scholar
  113. Paglino JC, Pomper GJ, Fisch GS et al (2004) Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 44:16–24PubMedGoogle Scholar
  114. Peters C (2009) Granulocyte transfusions in neutropenic patients: beneficial effects proven? Vox Sang 96:275–283PubMedGoogle Scholar
  115. Popovsky MA (2000) Transfusion-related acute lung injury. Curr Opin Hematol 7:402–407PubMedGoogle Scholar
  116. Ray CE Jr, Shenoy SS (1997) Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 204:97–99PubMedGoogle Scholar
  117. Rebulla P (2001) Platelet transfusion trigger in difficult patients. Transfus Clin Biol 8:249–254PubMedGoogle Scholar
  118. Rebulla P, Finazzi G, Marangoni F et al (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med 337:1870–1875PubMedGoogle Scholar
  119. Rintels PB, Kenney RM, Crowley JP (1994) Therapeutic support of the patient with thrombocytopenia. Hematol Oncol Clin North Am 8:1131–1157PubMedGoogle Scholar
  120. Robinson SP, Marks DI (2004) Granulocyte transfusion in the G-CSF era. Where do we stand? Bone Marrow Transplant 34:839–846PubMedGoogle Scholar
  121. Roseff SD, Luban NL, Manno CS (2002) Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42:1398–1413PubMedGoogle Scholar
  122. Rossetto CL, McMahon JE (2000) Current and future trends in transfusion therapy. J Pediatr Oncol Nurs 17:160–170PubMedGoogle Scholar
  123. Rubin RH, Tolkoff-Rubin NE, Oliver D et al (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40:243–249PubMedGoogle Scholar
  124. Ruccione KS, Midambi K, Sposto R et al (2012) Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatr Blood Cancer 59:697–702PubMedGoogle Scholar
  125. Ruggiero A, Riccardi R (2002) Interventions for anemia in pediatric cancer patients. Med Pediatr Oncol 39:451–454PubMedGoogle Scholar
  126. Rühl H, Bein G, Sachs UJ (2009) Transfusion-associated graft-versus-host disease. Transfus Med Rev 23:62–71PubMedGoogle Scholar
  127. Sachs UJ, Reiter A, Walter T et al (2006) Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 46:1909–1914PubMedGoogle Scholar
  128. Sanchez R, Toy P (2005) Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 45:248–255PubMedGoogle Scholar
  129. Sanders RP, Maddirala SD, Geiger TL et al (2005) Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 130:781–787PubMedGoogle Scholar
  130. Schiffer CA (1991) Prevention of alloimmunization against platelets. Blood 77:1–4PubMedGoogle Scholar
  131. Schiffer CA, Lee EJ, Ness PM et al (1986) Clinical evaluation of platelet concentrates stored for one to five days. Blood 67:1591–1594PubMedGoogle Scholar
  132. Schiffer CA, Anderson KC, Bennett CL et al (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1519–1538PubMedGoogle Scholar
  133. Schrezenmeier H, Walther-Wenke G, Müller TH et al (2007) Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47:644–652PubMedGoogle Scholar
  134. Seidel MG, Peters C, Wacker A et al (2008) Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 42:679–684PubMedGoogle Scholar
  135. Shander A, Cappellini MD, Goodnough LT (2009) Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang 97:185–197PubMedGoogle Scholar
  136. Silliman CC, Boshkov LK, Mehdizadehkashi Z et al (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101:454–462PubMedGoogle Scholar
  137. Slichter SJ, Harker LA (1978) Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 7:523–539PubMedGoogle Scholar
  138. Sobrero A, Puglisi F, Guglielmi A et al (2001) Fatigue: a main component of anemia symptomatology. Semin Oncol 28:15–18PubMedGoogle Scholar
  139. St Pierre TG, Clark PR, Chau-anusorn W et al (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105:855–861PubMedGoogle Scholar
  140. Stainsby D, Jones H, Asher D et al (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20:273–282PubMedGoogle Scholar
  141. Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801PubMedGoogle Scholar
  142. Stellato TA, Gauderer MW, Lazarus HM et al (1985) Percutaneous silastic catheter insertion in patients with thrombocytopenia. Cancer 56:2691–2693PubMedGoogle Scholar
  143. Strauss RG, Barnes A Jr, Blanchette VS et al (1990) Directed and limited-exposure blood donations for infants and children. Transfusion 30:68–72PubMedGoogle Scholar
  144. Tas F, Eralp Y, Basaran M et al (2002) Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol 25:371–379PubMedGoogle Scholar
  145. te Loo DM, Kamps WA, van der Does-van den Berg A et al (2006) Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol 24:2332–2336Google Scholar
  146. The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861–1869Google Scholar
  147. Thiele T, Krüger W, Zimmermann K et al (2011) Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME). Transfusion 51:2620–2626PubMedGoogle Scholar
  148. Vamvakas EC (2005) Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 19:181–199PubMedGoogle Scholar
  149. Vamvakas EC, Blajchman MA (2001) Universal WBC reduction: the case for and against. Transfusion 41:691–712PubMedGoogle Scholar
  150. Vamvakas ED, Pineda AA (1997) Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apher 12:74–81PubMedGoogle Scholar
  151. van de Wetering MD, Weggelaar N, Offinga M et al (2007) Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer 43:2082–2092PubMedGoogle Scholar
  152. van Marwijk Kooy M, van Prooijen HC, Moes M et al (1991) Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 77:201–205PubMedGoogle Scholar
  153. Wagner S (1997) Transfusion-related bacterial sepsis. Curr Opin Hematol 4:464–469PubMedGoogle Scholar
  154. Wandt H, Frank M, Ehninger G et al (1998) Safety and cost effectiveness of a 103 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 203 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91:3601–3606PubMedGoogle Scholar
  155. Wang SE, Lara PN, Lee-Ow A et al (2002) Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol 70:191–194PubMedGoogle Scholar
  156. Welch HG, Larson EB, Slichter SJ (1989) Providing platelets for refractory patients. Prudent strategies. Transfusion 29:193–195PubMedGoogle Scholar
  157. Williamson LM, Lowe S, Love EM et al (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319:16–19PubMedCentralPubMedGoogle Scholar
  158. Wong EC, Perez-Albuerne E, Moscow JA, Luban NL (2005) Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists. Pediatr Blood Cancer 44:119–127PubMedGoogle Scholar
  159. Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460–1465PubMedCentralPubMedGoogle Scholar
  160. Yazer MH, Podlosky L, Clarke G, Nahirniak SM (2004) The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 44:10–15PubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2015

Authors and Affiliations

  • Esteban Gomez
    • 1
  • Anurag K. Agrawal
    • 1
    Email author
  • Caroline A. Hastings
    • 1
  1. 1.Department of Hematology/OncologyChildren’s Hospital and Research Center OaklandOaklandUSA

Personalised recommendations